Asensus Surgical, Inc.
ASXC
ASXC was delisted on the 21st of August, 2024.
80 hedge funds and large institutions have $13.5M invested in Asensus Surgical, Inc. in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 22 reducing their positions, and 8 closing their positions.
257% more call options, than puts
Call options by funds: $318K | Put options by funds: $89K
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
1% more funds holding
Funds holding: 79 → 80 (+1)
23% less capital invested
Capital invested by funds: $17.5M → $13.5M (-$4M)
59% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$93.8K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$90.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$30.9K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$30.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$27.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$121K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$95.2K |
| 3 |
Renaissance Technologies
New York
|
-$45.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.9K |
| 5 |
PSP
Pacific Sage Partners
Edmonds,
Washington
|
-$21.5K |
ASXC Hedge Fund Activity: Q2 2023 in Review
80 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2023, worth a combined $13.5M — down 23% from $17.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ASXC positions and 8 closed out — a net gain of 1 holder — while 9 added to existing stakes and 22 trimmed.
The largest buyer was Masters Capital Management, adding an estimated $93.8K. The largest seller was Millennium Management, cutting an estimated $121K.
- 80 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2023, up from 79 in Q1 2023.
- Funds reported $13.5M of Asensus Surgical, Inc. stock for Q2 2023, down 23% quarter-over-quarter.
- 9 funds opened new Asensus Surgical, Inc. positions in Q2 2023 and 8 closed out, a net change of +1 holder.
- The largest Asensus Surgical, Inc. buyer in Q2 2023 was Masters Capital Management, an estimated $93.8K added.
- The largest Asensus Surgical, Inc. seller in Q2 2023 was Millennium Management, an estimated $121K sold.
Based on aggregated 13F filings for Q2 2023.